NCT07000929 is a clinical trial of Videonystagmography in Migraine Disorders, sponsored by Dr. med. Lukas Becker.

Who is sponsoring NCT07000929?

NCT07000929 is sponsored by Dr. med. Lukas Becker.

What drugs are being tested in NCT07000929?

Interventions in NCT07000929: Videonystagmography.

What condition does NCT07000929 study?

NCT07000929 studies Migraine Disorders, Vertigo.

Is NCT07000929 still recruiting?

NCT07000929 is currently completed. Last updated 27 February 2026.

Last reviewed 2026-02-27 · How we verify

NCT07000929

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Videonystagmography and Vestibular Migraine

Completed Last updated 27 February 2026

What this trial tests

trial testing Videonystagmography in Migraine Disorders in 173 participants. Completed in 31 December 2025.

Timeline

16 October 2023

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	Dr. med. Lukas Becker
Status	Completed
Study type	OBSERVATIONAL
Enrollment	173
Start date	16 October 2023
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	1 location across Germany

Drugs / interventions tested

Videonystagmography

Conditions studied

Migraine Disorders — all drugs for Migraine Disorders →
Vertigo — all drugs for Vertigo →

Sponsor

Dr. med. Lukas Becker

Who can join

18 and older, any sex, with Migraine Disorders or Vertigo. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the study, the investigators would like to examine whether there is a difference between patients with vestibular migraine, patients with episodic or chronic migraine and healthy subjects in the examination of videonystagmography, which has been used for many years to differentiate and diagnose vertigo disorders. Accordingly, videonystagmography could also be discussed as an important diagnostic instrument for the diagnosis of the still young disease vestibular migraine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Migraine Disorders

Currently open trials in the same condition.

NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
NCT07093138 — Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatmen · Phase 4 · recruiting
NCT06426316 — The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. · NA · recruiting
NCT06623188 — Treatment of Episodic Migraine With AURICular Neuromodulation · NA · recruiting
NCT06535880 — Trigeminal Brainstem Mapping 2: Higher Cortical Strucureas As Well As Subnuclei of the Spinal Trigeminal Nucleus · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07000929 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. med. Lukas Becker
Last refreshed: 27 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07000929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing